Xtant Medical Holdings Inc [AMEX: XTNT] loss -1.88% or -0.01 points to close at $0.59 with a heavy trading volume of 118507 shares.
It opened the trading session at $0.6435, the shares rose to $0.6435 and dropped to $0.5715, the range by which the price of stock traded the whole day. The daily chart for XTNT points out that the company has recorded 61.27% gains over the past six months.
If we look at the average trading volume of 186.36K shares, XTNT reached to a volume of 118507 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Xtant Medical Holdings Inc [XTNT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XTNT shares is $1.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XTNT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Xtant Medical Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 05, 2023. While these analysts kept the previous recommendation, Maxim Group raised their target price from $10 to $6. The new note on the price target was released on November 15, 2018, representing the official price target for Xtant Medical Holdings Inc stock. Previously, the target price had yet another drop from $18 to $10, while Maxim Group kept a Buy rating on XTNT stock.
The Average True Range (ATR) for Xtant Medical Holdings Inc is set at 0.06, with the Price to Sales ratio for XTNT stock in the period of the last 12 months amounting to 0.67. The Price to Book ratio for the last quarter was 1.87, with the Price to Cash per share for the same quarter was set at 0.04.
Trading performance analysis for XTNT stock
Xtant Medical Holdings Inc [XTNT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -12.46. With this latest performance, XTNT shares dropped by -17.65% in over the last four-week period, additionally plugging by 61.27% over the last 6 months – not to mention a drop of -21.60% in the past year of trading.
Xtant Medical Holdings Inc [XTNT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Xtant Medical Holdings Inc [XTNT] shares currently have an operating margin of -6.17% and a Gross Margin at 58.18%. Xtant Medical Holdings Inc’s Net Margin is presently recorded at -9.81%.
Return on Equity for this stock declined to -12.64%, with Return on Assets sitting at -12.64%.
An analysis of Institutional ownership at Xtant Medical Holdings Inc [XTNT]
There are presently around $57.58%, or 67.49%% of XTNT stock, in the hands of institutional investors. The top three institutional holders of XTNT stocks are: ORBIMED ADVISORS LLC with ownership of 73.11 million shares, which is approximately 56.1256%. ALTIUM CAPITAL MANAGEMENT LP, holding 7.42 million shares of the stock with an approximate value of $$4.67 million in XTNT stocks shares; and ALTIUM CAPITAL MANAGEMENT LP, currently with $$2.26 million in XTNT stock with ownership which is approximately 2.7481%.
